Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periodontal debridement with local antimicrobial gels or film for chronic periodontitis
RBR-226f6jPhase 2Not yet recruiting
- Sponsor
- Faculdade de Odontologia de Ribeirão Preto
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of doxycycline and metronidazole in chronic periodontitis and gingival disease (4 arms), sponsored by Faculdade de Odontologia de Ribeirão Preto. Primary endpoints: Clinical evaluation after treatment and Microbiological evaluation after treatment. Planned start May 2020; status: not yet recruiting.
02
Drugs
doxycyclinemetronidazole
03
Conditions
chronic periodontitisgingival disease
Beyond the preview
Go deeper on RBR-226f6j.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-226f6j.